- Austria / Österreich
- Bosnia and Herzegovina / Босна и Херцеговина
- Bulgaria / България
- Croatia / Hrvatska
- Czech Republic & Slovakia / Česká republika & Slovensko
- Finland / Suomi
- France / France
- Germany / Deutschland
- Greece / ΕΛΛΑΔΑ
- Italy / Italia
- Netherlands / Nederland
- Nordic / Nordic
- Poland / Polska
- Portugal / Portugal
- Romania & Moldova / România & Moldova
- Russia / Россия
- Slovenia / Slovenija
- Serbia & Montenegro / Србија и Црна Гора
- Spain / España
- Switzerland / Schweiz
- Turkey / Türkiye
- UK & Ireland / UK & Ireland
BEIJING, China: When the largest Chinese clear aligner manufacturer floated shares on the Hong Kong stock exchange in June, it was obliged to make available to the public company and market information that previously had been difficult to obtain. Angelalign’s trading prospectus outlines the exceptional market growth that is forecast for orthodontic therapy in China by 2030, by which time the country is expected to have more clear aligner treatments per year than the US or Europe.
The primary source of market information that was included in Angelalign’s trading prospectus was taken from a commissioned report by the Hong Kong-based China Insights Consultancy (CIC).
According to the report, the total value of dental care services in China doubled from $13.2 billion in 2015 to $26.2 billion in 2020 (from €12.4 billion to €21.7 billion, based on 1 December 2015 and 1 December 2020 exchange rates). Accordingly, last year, the value of dental services in China was equal to around one-fifth of the total value of dental services in the US, which was a reported $133.2 billion. The orthodontics market in China, in terms of revenue from retail sales, was worth $3.4 billion in 2015 and this more than doubled to reach $7.9 billion in 2020. During this period, the number of orthodontic cases in the country increased from 1.6 million to 3.1 million.
The CIC report estimates that, by 2030, 9.5 million people in China will undergo some form of orthodontic treatment annually, surpassing estimated cases in the US (6.9 million), Europe (5.9 million) and the wider Asia Pacific region (5.7 million). The factors driving the growth in orthodontic treatment in the country are similar to those that have caused market growth in other countries—growing affluence, a heightened awareness of oral health and dental aesthetics, and an increasing number of dentists and hospitals providing orthodontic care, according to CIC.
Clear aligners taking a greater share of orthodontics cases in China
The continued global increase in clear aligner cases is mainly driven by the popularisation of the therapy outside of the most established clear aligner markets—the US and Europe. Clear aligners first became available in China in 2010, and by 2019, the country was the second-largest market after the US. Most of this expansion has occurred in the last five years.
In 2015, retails sales of clear aligner trays in China were worth $0.2 billion, and this increased to $1.5 billion in 2020. During this period, the number of orthodontic treatments addressed using clear aligner therapy in China increased from 47,800 to 335,500. The CIC report estimates that a compound annual growth rate of 23.1% will propel the country’s clear aligner market to a retail value of $11.9 billion by 2030, by which time 3.8 million orthodontic treatments are expected to be addressed annually using clear aligner therapy. This estimate from the report would put China ahead of the US (3.7 million clear aligner treatments), Europe (1.9 million), the wider Asia Pacific region (1.7 million) and the rest of the world (0.8 million).
The traditional orthodontics market, however, is expected to endure and remain dominant in China. The value of retail sales of fixed appliances is currently estimated at $6.9 billion, compared with $2.0 billion from clear aligners. By 2030, it is estimated that sales of fixed appliances will generate $17.7 billion in sales and that clear aligner sales will generate $11.9 billion, the report states.
“[Among] the 3.1 million treated malocclusion cases in China in 2020, only 11.0% were addressed with clear aligners”
Angelalign said in its prospectus: “China’s clear aligner market is still at a nascent stage. In 2020, China had approximately 1,040 million malocclusion cases, much higher than that of approximately 245 million in the United States. However, among the 3.1 million treated malocclusion cases in China in 2020, only 11.0% were addressed with clear aligners, whereas 31.9% of the 4.4 million treated malocclusion cases in the United States were addressed with clear aligners. Such significant disparities indicate a huge underpenetrated clear aligner market in China.”
The prospectus said that an increased willingness to receive treatment for malocclusion was a driving force behind the growing popularity of clear aligner treatment, as were technological advancement in clear aligner therapy and the visualisation of treatment results using intra-oral scanning technology.
Angelalign Technology shared the majority of the clear aligner market in China with its biggest competitor, US-based Align Technology. Angelalign said in its prospectus that, in 2020, it accounted for 41.0% of the market (137,600 case shipments), that Align Technology accounted for 41.1% (138,900 cases), that a second, unnamed competitor accounted for 8.6% of the market (29,000 cases) and that smaller competitors accounted for an aggregate 9.0% (30,100 cases).
Angelalign is the largest competitor of Align Technology, based on the number of clear aligners that the company supplies. China accounted for 8% of Align technology’s total revenue in 2019 and was one of the company’s largest country markets.
A PDF copy of the Angelalign Technology prospectus can be accessed here.